InvestorsHub Logo
Followers 5
Posts 1109
Boards Moderated 0
Alias Born 05/02/2014

Re: chillout post# 10113

Monday, 07/07/2014 9:48:12 AM

Monday, July 07, 2014 9:48:12 AM

Post# of 140474
I'm an engineer and have spent enough time around top surgeons and ORs to bet Titan will need to partner (or be bought) by someone really big within the next 1.5 years.
Reason: Too risky and expensive to get a product like this through FDA approval, and fight lawsuits. If they hope to entrench into the US market, they will need a brand name and deep pockets to lean on. ISRG had the "revolutionary" card to play, because they were first. Cost compared to DaVinci counts, but not so much as you might think in large hospital environments that set the stage for new surgeons. Outcomes are the metric, and even DaVinci is not in the clear with proving its outcomes are better.
So far in looking at the few videos by Titan, no surgeon I have told about Titan has said "wow". That bothers me because a lot of posters here think this thing is automatically the second coming.
I am long on Titan with 10k shares, but I hope they've got a lot more that we haven't seen yet, if they think they are going to go it alone.